To build capacity and strengthen less established institutions, including infrastructure for conducting clinical trials, for the identification, treatment and prevention of poverty-related infectious diseases, including emerging and re-emerging diseases in the Southern Region of Africa.
To be a regional network of excellence capable of reducing the individual, social and economic burden of infectious diseases related to sub-Saharan poverty by supporting collaborative research to develop appropriate and accessible medical interventions.
To build capacity and strengthen less established institutions, including infrastructure for conducting clinical trials.
Trials of Excellence in Southern Africa (TESA) network was launched in 2009, during the European and Developing Countries Clinical Trials Partnership (EDCTP) phase 1. At this stage, nine institutions from six different countries from Southern Africa were part of this consortium whose aim was to creating a framework for collaboration, capacity building and training among member institutions. Currently, TESA II, incorporating thirteen institutions from eight Southern African and four European countries, which are predisposed to strengthen clinical research capacities in Southern Africa, as well as to increase North-South South- South networks among member institutions.
List of partner’s countries and institutions
TESA II is a consortium composed by the following institutions which represent the core of the regional network: